{
    "nct_id": "NCT03944265",
    "official_title": "Using Genetics and Shared Decision Making to Improve Lung Cancer Care: A Developmental Study",
    "inclusion_criteria": "* Newly diagnosed with advanced NSCLC (stage IV a-c) that are wild-type for activating genetic alterations (EGFR, ROS 1, and ALK).\n* May or may not be candidates for immune checkpoint therapy.\n* May have had 1-any number of prior systemic therapy regimens.\n* If prior systemic regimen, must have progression disease at time of evaluation.\n* Untreated brain metastases permitted.\n* Completed pathological analysis of tumor tissue.\n* Patients who have exhausted targeting therapy options.\n* Can speak and read English.\n* All participants must be willing to comply with all study procedures and be available for the duration of the study.\n* Providers: Those who treat NSCLC patients as described above.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "â€¢ There are no specific exclusions in this trial for particular medical conditions, comorbidities, or performance status. Any patient deemed appropriate to be considered for evaluation and/or treatment would be appropriate to include in this trial.",
    "miscellaneous_criteria": ""
}